599 Highly-effective CFTR modulator therapy with elexacaftor-tezacaftorivacaftor leads to age-dependent changes in cystic fibrosis microbiology—data from the German cystic fibrosis registry

Autor: Dittrich, A., Sieber, S., Naehrlich, L., Burkhart, M., Hafkemeyer, S., Tümmler, B.
Zdroj: In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S318-S318
Databáze: ScienceDirect